Physician profile

Atif Bashir

Interventional Cardiology · Wellington, FL

NPI 1316246739

$13,601.36

in general payments reported to CMS, 2019-2025

43 companies · $1,096 in 2025

The $1,096 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,663.75
Consulting Fee$3,440.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $4,398.04 2019-2025 Edwards Sapien 3 Ultra Transcatheter Heart Valve, Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia
Abbott Laboratories $2,332.94 2019-2024 Aveir, Jot Dx, Amplatzer Amulet
Boston Scientific Corporation $881.85 2019-2025 Watchman, Watchman Flx, Ekosonic
Abiomed $688.83 2020-2025 Impella
Janssen Pharmaceuticals, INC $556.34 2021-2024 Xarelto
Novartis Pharmaceuticals Corporation $399.56 2020-2025
Philips North America LLC $382.68 2019-2023
Medtronic, INC. $357.16 2021-2024 Linq II, Reveal Linq
Cordis US Corp. $304.05 2022-2024 Stabilizer, Mynxgrip, Wizdom
Penumbra, INC. $210.74 2020-2024 Penumbra System, Indigo System
Shockwave Medical, INC $210.63 2021-2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Sanofi-Aventis U.S. LLC $210.62 2021-2024
Inari Medical, INC. $197.22 2022-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Pfizer INC. $196.48 2019-2025
E.R. Squibb & Sons, L.L.C. $192.27 2022-2025 Camzyos, Eliquis
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $184.67 2021-2025 Repatha, Repatha
Merck Sharp & Dohme LLC $147.67 2022-2025 Verquvo
Cvrx, INC. $139.81 2023-2025 Barostim Neo System
Boehringer Ingelheim Pharmaceuticals, INC. $136.11 2022-2024 Jardiance
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $130.64 2019-2025 Lifevest
Actelion Pharmaceuticals US, INC. $130.07 2021-2023 Opsumit, Uptravi
Chiesi USA, INC. $123.91 2019
Astrazeneca Pharmaceuticals LP $117.23 2020-2024 Farxiga
Heartflow, INC. $113.33 2023 Ffrct
Medtronic Vascular, INC. $112.60 2019-2020
Bayer Healthcare Pharmaceuticals INC. $109.25 2021-2025
Kestra Medical Technology Services, INC. $106.07 2023-2024 Assure Wcd
Esperion Therapeutics, INC. $105.11 2023-2025 Nexletol
W. L. Gore & Associates, INC. $61.81 2021
Novo Nordisk INC $46.78 2024-2025 Wegovy
Lexicon Pharmaceuticals, INC. $45.30 2024
Vital Connect, INC $42.67 2025 Vitalpatch Rtm
Biosense Webster, INC. $40.22 2020
Cardiva Medical, INC. $29.53 2022
Impulse Dynamics (USA) INC. $27.50 2023 Optimizer
Ge Healthcare $26.82 2022
Astellas Pharma US INC $16.99 2021
Siemens Medical Solutions USA, INC. $16.70 2022
Baxter Healthcare $16.62 2023 Hillrom - Cardiac Ambulatory Monitor
Kci USA, INC. $16.04 2021
Alnylam Pharmaceuticals INC. $13.50 2025 Onpattro
Terumo Medical Corporation $12.62 2021
Cardiovascular Systems INC. $12.38 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Atif Bashir

$13,601.36

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $1,096 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/941199/atif-bashir

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.